DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,058 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $524,448 | -51.2% | 2,267 | -47.7% | 1.36% | -24.8% |
Q3 2023 | $1,074,769 | +13.3% | 4,332 | +9.6% | 1.80% | +18.3% |
Q2 2023 | $948,720 | -4.4% | 3,953 | +0.4% | 1.52% | -16.5% |
Q1 2023 | $992,029 | +5.3% | 3,936 | +10.9% | 1.82% | -10.3% |
Q4 2022 | $941,976 | +4.0% | 3,549 | +1.2% | 2.04% | -2.5% |
Q3 2022 | $906,000 | +0.2% | 3,506 | -1.6% | 2.09% | +19.5% |
Q2 2022 | $904,000 | -12.6% | 3,564 | +1.1% | 1.75% | +7.0% |
Q1 2022 | $1,034,000 | -7.5% | 3,524 | +3.7% | 1.63% | -0.6% |
Q4 2021 | $1,118,000 | -5.1% | 3,399 | -12.2% | 1.64% | -16.0% |
Q3 2021 | $1,178,000 | +0.9% | 3,872 | -10.9% | 1.96% | +1.2% |
Q2 2021 | $1,167,000 | +6.8% | 4,347 | -10.5% | 1.93% | +3.2% |
Q1 2021 | $1,093,000 | -7.3% | 4,857 | -8.5% | 1.87% | -8.5% |
Q4 2020 | $1,179,000 | +3.2% | 5,310 | +0.1% | 2.05% | -2.7% |
Q3 2020 | $1,142,000 | +23.7% | 5,305 | +1.7% | 2.10% | +16.3% |
Q2 2020 | $923,000 | +27.8% | 5,215 | 0.0% | 1.81% | +8.6% |
Q1 2020 | $722,000 | -4.6% | 5,215 | +5.7% | 1.67% | +24.3% |
Q4 2019 | $757,000 | +4.4% | 4,935 | -1.6% | 1.34% | -3.0% |
Q3 2019 | $725,000 | +16.2% | 5,015 | +14.9% | 1.38% | +16.6% |
Q2 2019 | $624,000 | +8.0% | 4,365 | -0.3% | 1.18% | +8.2% |
Q1 2019 | $578,000 | +14.2% | 4,380 | -10.8% | 1.09% | +2.1% |
Q4 2018 | $506,000 | -4.9% | 4,910 | +0.3% | 1.07% | +11.1% |
Q3 2018 | $532,000 | +10.4% | 4,895 | +0.2% | 0.96% | +1.3% |
Q2 2018 | $482,000 | +1.7% | 4,885 | +0.9% | 0.95% | -0.4% |
Q1 2018 | $474,000 | +5.6% | 4,840 | 0.0% | 0.96% | +15.9% |
Q4 2017 | $449,000 | +8.2% | 4,840 | 0.0% | 0.83% | +4.0% |
Q3 2017 | $415,000 | +11.9% | 4,840 | +10.0% | 0.79% | +8.2% |
Q2 2017 | $371,000 | +8.5% | 4,400 | +10.1% | 0.73% | +1.4% |
Q1 2017 | $342,000 | +41.9% | 3,995 | +29.1% | 0.72% | +29.5% |
Q4 2016 | $241,000 | +6.2% | 3,095 | +6.9% | 0.56% | +2842.1% |
Q3 2016 | $227,000 | -18.1% | 2,895 | +5.5% | 0.02% | -52.5% |
Q2 2016 | $277,000 | – | 2,745 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |